14th Jun 2012

New funding oppourtunities from the NIHR HTA

The National Institute for Health Research Health Technology Assessment (NIHR HTA) programme has realeased news on its latest funding opportunities.

The NIHR HTA is the largest and longest running of the Department of Health's national research programmes. Through the programme they produce independent research information on the effectiveness, costs and broader impact of healthcare treatments and tests.

The NIHR HTA are currently seeking research proposals on:

Primary Research (Two stage outline to full proposal)

  • 12/17 Barriers and facilitators to uptake of vaccinations in travelling communities
  • 12/19 Ultrasound elastography in the diagnosis of thyroid cancer
  • 12/21 Communication therapy post-stroke
  • 12/22 Photodynamic therapy for recurrent head and neck cancer
  • 12/23 Intradialytic exercise in renal failure
  • 12/24 UVB light combined with topical corticosteroid for treatment of vitiligo
  • 12/25 Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation
  • 12/26 Psychotherapy for psychogenic non-epileptic seizures
  • 12/28 Non-pharmacological interventions to reduce weight gain in people with schizophrenia prescribed antipsychotic medication
  • 12/29 Nitroglycerin for management of retained placenta
  • 12/30 Treatments for severe chronic hand eczema
  • 12/31 Do 'phosphate binders' reduce mortality and improve quality of life in patients with advanced kidney disease?

Evidence Synthesis (single stage full proposal)

  • 12/27 Art therapy for people with non-psychotic mental disorders
    Clinical Evaluation and Trials

Researchers are asked to submit outline proposals for evaluation studies within the remit of the HTA programme. HTA is inviting Evidence Synthesis applicants to submit using a single stage application process. Primary research applications will be accepted in the usual way. The HTA programme are interested in receiving proposals addressing any health problem in areas not otherwise well covered in their portfolio.

For more information and how to apply, please visit  here

The closing dates for submissions are:

  • Primary Research proposals and Evidence Synthesis proposals - 2 July 2012
  • Clinical Evaluation and Trials - 3 September 2012.

    Share this :